Welcome to AMIGOs

Australasian Merkel Cell Carcinoma Interest Group

“Enabling access to high quality care for all patients with Merkel Cell Carcinoma”

Find out more

What is Merkel Cell Carcinoma?

Merkel Cell Carcinoma is a rare but highly aggressive neuroendocrine skin cancer.

Merkel Cell Carcinoma has the potential to be lethal and appropriate management should be sought immediately through a specialist centre.
Treatment often will involve several types of therapy such as surgery, radiation, and sometimes systemic medications. Multidisciplinary evaluation of patients with this cancer is critical to determine and carry out a proper treatment plan.
A list of specialist centres who are able to provide you with advice are available here.

“Many patients and primary care doctors don’t understand the severity of a Merkel Cell Carcinoma diagnosis. Carers and families often don’t appreciate the seriousness of the condition. How could a skin cancer that you have never heard of, give you a deadly problem, unless it is malignant melanoma? Merkel Cell Carcinoma patients need quick referral to specialists at centres of excellence who understand this disease.”

Jonathan Pincus
Chair, Patient Advocacy Group

Newsfeed

Always fantastic to see clinical trials having a positive impact on real-world patient outcomes - https://t.co/YK4F3o8nSF @amigos_masc #GOTHAM #merklecellcarcinoma #skincancer #collaboration

The first site for the IMAT trial is NOW OPEN. Congratulations to Dr Wen Xu, Study Chair, Mark Shackleton @mark_shacks and the @AlfredHealth team. The IMAT trial looks to develop a more effective strategy for the management of early stage Merkel Cell Carcinoma.

The first site for the GoTHAM trial is OPEN at
@PeterMacCC. Congratulations to A/Prof
@Shahneen3 & the team involved in this world-first study to develop a more effective strategy for the management of late stage Merkel Cell Carcinoma #clinicaltrials #fightcancer

Load More...